Embecta (NASDAQ:EMBC) Updates FY 2023 Earnings Guidance

Embecta (NASDAQ:EMBC – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $2.50-$2.60 for the period, compared to the consensus earnings per share estimate of $2.09. The company issued revenue guidance of $1.10 billion-$1.11 billion, compared to the consensus revenue estimate of $1.10 billion.

Embecta Price Performance

Shares of EMBC stock traded up $0.34 during trading hours on Friday, hitting $27.56. The company had a trading volume of 101,995 shares, compared to its average volume of 637,293. The company’s fifty day moving average is $28.67 and its 200 day moving average is $29.18. Embecta has a fifty-two week low of $22.30 and a fifty-two week high of $36.64. The stock has a market capitalization of $1.58 billion and a PE ratio of 16.60.

Embecta Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 13th. Stockholders of record on Monday, May 29th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, May 25th. This represents a $0.60 annualized dividend and a dividend yield of 2.18%. Embecta’s dividend payout ratio is currently 37.04%.

Institutional Investors Weigh In On Embecta

Hedge funds have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC lifted its holdings in Embecta by 493.8% during the 1st quarter. Tower Research Capital LLC TRC now owns 2,280 shares of the company’s stock worth $64,000 after buying an additional 1,896 shares in the last quarter. State of Wyoming purchased a new stake in shares of Embecta in the 4th quarter valued at approximately $119,000. Meeder Asset Management Inc. increased its position in shares of Embecta by 853.9% in the 4th quarter. Meeder Asset Management Inc. now owns 5,113 shares of the company’s stock valued at $129,000 after purchasing an additional 4,577 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Embecta by 728.7% in the 1st quarter. Russell Investments Group Ltd. now owns 6,820 shares of the company’s stock valued at $192,000 after purchasing an additional 5,997 shares during the last quarter. Finally, Franklin Resources Inc. purchased a new stake in shares of Embecta in the 1st quarter valued at approximately $208,000. 93.45% of the stock is currently owned by institutional investors and hedge funds.

About Embecta

(Get Rating)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.